Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases. A crucial step toward their successful clinical application is to examine the immune response that might be launched against them after transplantation. We used two experimental platforms to examine the in vivo leukocyte response toward hESCs. First, immunocompetent and immunodeficient mouse strains were used to identify T cells as the major component that causes xenorejection of hESCs. Second, mice that were conditioned to carry peripheral blood leukocytes from human origin were used to test the human leukocyte alloresponse toward undifferentiated and differentiated hESCs. Using this model, we have detected only a minute immune response toward undifferentiated as well as differentiated hESCs over the course of 1 month, although control adult grafts were repeatedly infiltrated with lymphocytes and destroyed. Our data show that the cells evade immune destruction due to a low immunostimulatory potential. Nevertheless, a human cytotoxic T lymphocyte clone that was specifically prepared to recognize two hESC lines could lyse the cells after major histocompatibility complex class I (MHC-I) induction. Although MHC-I levels in hESCs are sufficient for rejection by cytotoxic T cells, our data suggest that the immunostimulatory capacity of the cells is very low. Thus, immunosuppressive regimens for hESC-based therapeutics could be highly reduced compared with conventional organ transplantation because direct allorejection processes of hESCs and their derivatives are considerably weaker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although most of the pluripotent stem cells have low HLA expression [93], iPSC derivatives can trigger an immune response.”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [93]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
In vitro differentiation of transplantable neural precursors from human embryonic stem cells
Zhang, S.-C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1129 · Cited by 1,912
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., & Benvenisty, N. (2000) · Molecular Medicine · doi:10.1007/bf03401776 · Cited by 1,500
Self-citationPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A., & Benvenisty, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11307 · Cited by 1,134
Self-citationNeural progenitors from human embryonic stem cells
Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., & Ben-Hur, T. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1134 · Cited by 1,119
Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068356.38592.68 · Cited by 1,001
Hematopoietic colony-forming cells derived from human embryonic stem cells
Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R., & Thomson, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191362598 · Cited by 925
Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells
Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002) · Circulation Research · doi:10.1161/01.res.0000035254.80718.91 · Cited by 902
Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Self-citationEndothelial cells derived from human embryonic stem cells
Levenberg, S., Golub, J. S., Amit, M., Itskovitz-Eldor, J., & Langer, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032074999 · Cited by 817
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
Macrophage inflammatory protein-1
Menten, P., Wuyts, A., & Van Damme, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00045-x · Cited by 706
Characterization of the expression of MHC proteins in human embryonic stem cells
Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., Reubinoff, B., Mandelboim, O., & Benvenisty, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298299 · Cited by 671
Self-citationCytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells
Chadwick, K., Wang, L., Li, L., Menendez, P., Murdoch, B., Rouleau, A., & Bhatia, M. (2003) · Blood · doi:10.1182/blood-2003-03-0832 · Cited by 605
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
Enrichment of Neurons and Neural Precursors from Human Embryonic Stem Cells
Carpenter, M. K., Inokuma, M. S., Denham, J., Mujtaba, T., Chiu, C.-P., & Rao, M. S. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7832 · Cited by 501
Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells
Rambhatla, L., Chiu, C.-P., Kundu, P., Peng, Y., & Carpenter, M. K. (2003) · Cell Transplantation · doi:10.3727/000000003783985179 · Cited by 437
Induced neuronal differentiation of human embryonic stem cells
Schuldiner, M., Eiges, R., Eden, A., Yanuka, O., Itskovitz-Eldor, J., Goldstein, R. S., & Benvenisty, N. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02776-7 · Cited by 425
Self-citationHuman Embryonic Stem Cells Possess Immune‐Privileged Properties
Li, L., Baroja, M. L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J., et al. (2004) · STEM CELLS · doi:10.1634/stemcells.22-4-448 · Cited by 360
Cardiomyocyte differentiation of mouse and human embryonic stem cells*
Mummery, C., Ward, D., Van Den Brink, C. E., Bird, S. D., Doevendans, P. A., Opthof, T., De La Riviere, A. B., Tertoolen, L., Van Der Heyden, M., & Pera, M. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00031.x · Cited by 302
Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., & Gepstein, L. (2002) · Circulation Research · doi:10.1161/01.res.0000039084.30342.9b · Cited by 298
Fändrich, F., Lin, X., Chai, G. X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.-S., Parwaresch, R., Zavazava, N., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-171 · Cited by 296
Human and porcine early kidney precursors as a new source for transplantation
Dekel, B., Burakova, T., Arditti, F. D., Reich-Zeliger, S., Milstein, O., Aviel-Ronen, S., Rechavi, G., Friedman, N., Kaminski, N., Passwell, J. H., et al. (2003) · Nature Medicine · doi:10.1038/nm812 · Cited by 291
Self-citationThe role of Fas ligand in immune privilege
Green, D. R., & Ferguson, T. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103104 · Cited by 284
In Vitro Osteogenic Differentiation of Human ES Cells
Sottile, V., Thomson, A., & McWhir, J. (2003) · Cloning and Stem Cells · doi:10.1089/153623003322234759 · Cited by 272
Differentiation and isolation of hepatic-like cells from human embryonic stem cells
Lavon, N., Yanuka, O., & Benvenisty, N. (2004) · Differentiation · doi:10.1111/j.1432-0436.2004.07205002.x · Cited by 262
Self-citationHLA-G expression during preimplantation human embryo development.
Jurisicova, A., Casper, R. F., MacLusky, N. J., Mills, G. B., & Librach, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.161 · Cited by 254
Kreisel, D., Krupnick, A. S., Gelman, A. E., Engels, F. H., Popma, S. H., Krasinskas, A. M., Balsara, K. R., Szeto, W. Y., Turka, L. A., & Rosengard, B. R. (2002) · Nature Medicine · doi:10.1038/nm0302-233 · Cited by 234
IL-1 and IL-18 receptors, and their extended family
Sims, J. E. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00306-5 · Cited by 211
Rogers, N. J., & Lechler, R. I. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.10201.x · Cited by 201
Marker succession during the development of keratinocytes from cultured human embryonic stem cells
Green, H., Easley, K., & Iuchi, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307226100 · Cited by 180
de Fougerolles, A. R., Qin, X., & Springer, T. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.619 · Cited by 168
Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro
Zhan, X., Dravid, G., Ye, Z., Hammond, H., Shamblott, M., Gearhart, J., & Cheng, L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16629-4 · Cited by 160
Directed neuronal differentiation of human embryonic stem cells
Schulz, T. C., Palmarini, G. M., Noggle, S. A., Weiler, D. A., Mitalipova, M. M., & Condie, B. G. (2003) · BMC Neuroscience · doi:10.1186/1471-2202-4-27 · Cited by 157
Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies
Dvash, T., Mayshar, Y., Darr, H., McElhaney, M., Barker, D., Yanuka, O., Kotkow, K. J., Rubin, L. L., Benvenisty, N., & Eiges, R. (2004) · Human Reproduction · doi:10.1093/humrep/deh529 · Cited by 145
Self-citationOrganized Development from Human Embryonic Stem Cells after Injection into Immunodeficient Mice
Gertow, K., Wolbank, S., Rozell, B., Sugars, R. V., Andäng, M., Parish, C. L., Lmreh, M. P., Wendel, M., & Ährlund‐Richter, L. (2004) · Stem Cells and Development · doi:10.1089/scd.2004.13.421 · Cited by 94
Engraftment of human peripheral blood lymphocytes in normal strains of mice
Lubin, I., Segall, H., Marcus, H., David, M., Kulova, L., Steinitz, M., Erlich, P. M., Gan, J., & Reisner, Y. (1994) · Blood · doi:10.1182/blood.v83.8.2368.2368 · Cited by 85
Self-citationTechnical Note: Aberrant Detection of Cell Surface Fas Ligand with Anti-Peptide Antibodies
Smith, D., Sieg, S., & Kaplan, D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4159 · Cited by 84
Enhanced Recognition of Human NK Receptors After Influenza Virus Infection
Achdout, H., Arnon, T. I., Markel, G., Gonen-Gross, T., Katz, G., Lieberman, N., Gazit, R., Joseph, A., Kedar, E., & Mandelboim, O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.915 · Cited by 71
Self-citationFas ligand deficiency in HIV disease
Sieg, S. F., Smith, D. G., Yildirim, Z., & Kaplan, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5860 · Cited by 47
Segall, H., Lubin, I., Marcus, H., Canaan, A., & Reisner, Y. (1996) · Blood · doi:10.1182/blood.v88.2.721.bloodjournal882721 · Cited by 45
Self-citationSmith, K. D., Mace, B. E., Valenzuela, A., Vigna, J. L., McCutcheon, J. A., Barbosa, J. A., Huczko, E. L., Engelhard, V. H., & Lutz, C. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2470 · Cited by 19
Dekel, B., Böcher, W. O., Marcus, H., Yussim, A., & Reisner, Y. (1999) · International Immunology · doi:10.1093/intimm/11.10.1673 · Cited by 17
Self-citation
Cited by
Embryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Risk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753
“Both ESC-derived cells [87-89] and especially MSCs [81,90,91] have been reported to be immune-privileged and have a low immunogenic potential.”
BackgroundHentze, H., Soong, P. L., Wang, S. T., Phillips, B. W., Putti, T. C., & Dunn, N. R. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.02.002 · Cited by 501
“A study by Drukker et al. established that T cells play a crucial role in the xenorejec-tion of implanted hESCs by comparing undifferentiated hESCs in immunocompetent versus immunodeficient mice (Drukker et al., 2006).”
Carr, A.-J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., Buchholz, D. E., Ahmado, A., Semo, M., Smart, M. J. K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008152 · Cited by 413
“immune responses[60–62].”
Biomaterials in cardiac tissue engineering: Ten years of research survey
Chen, Q.-Z., Harding, S. E., Ali, N. N., Lyon, A. R., & Boccaccini, A. R. (2008) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.08.001 · Cited by 382
Metadata
- Authors
- Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Weizmann Institute of Science (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
- Corresponding author
- Drukker, Micha
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-18
- Volume
- 24
- Issue
- 2
- Pages
- 221-229
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2006712783
- Cited by
- 402
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 30 · 2012: 34
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- human embryonic stem cells, immune rejection, xenotransplantation, allorejection, T cell response, cytotoxic T lymphocytes, MHC class I, immunodeficient mice, immunocompetent mice, cell therapy, immunosuppression
- MeSH terms
- Animals, Cell Differentiation, Embryo, Mammalian, Graft Rejection, Humans, Immunocompetence, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Stem Cells, T-Lymphocytes, Cytotoxic, Transplantation, Heterologous, T-Lymphocyte Subsets, Mice, SCID, Gene Expression Profiling, Stem Cell Transplantation, Tumor Necrosis Factors, Mice, Fas Ligand Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.